NO922551L - Polyhemoglobin stabilisert ved hjelp av purinderivater ogglutation - Google Patents

Polyhemoglobin stabilisert ved hjelp av purinderivater ogglutation

Info

Publication number
NO922551L
NO922551L NO92922551A NO922551A NO922551L NO 922551 L NO922551 L NO 922551L NO 92922551 A NO92922551 A NO 92922551A NO 922551 A NO922551 A NO 922551A NO 922551 L NO922551 L NO 922551L
Authority
NO
Norway
Prior art keywords
polyhemoglobin
glutation
stabilized
periodate
adenosine
Prior art date
Application number
NO92922551A
Other languages
English (en)
Other versions
NO309799B1 (no
NO922551D0 (no
Inventor
Mario Feola
Jan S Simoni
Peter C Canizaro
Original Assignee
Univ Texas Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas Tech filed Critical Univ Texas Tech
Publication of NO922551D0 publication Critical patent/NO922551D0/no
Publication of NO922551L publication Critical patent/NO922551L/no
Publication of NO309799B1 publication Critical patent/NO309799B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
NO922551A 1989-12-29 1992-06-26 AnalogifremgangsmÕte for fremstilling av et blodsubstitutt NO309799B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45907189A 1989-12-29 1989-12-29
PCT/US1990/007442 WO1991009615A1 (en) 1989-12-29 1990-12-12 Polyhemoglobin stabilized by purine derivatives and glutathione

Publications (3)

Publication Number Publication Date
NO922551D0 NO922551D0 (no) 1992-06-26
NO922551L true NO922551L (no) 1992-08-28
NO309799B1 NO309799B1 (no) 2001-04-02

Family

ID=23823294

Family Applications (1)

Application Number Title Priority Date Filing Date
NO922551A NO309799B1 (no) 1989-12-29 1992-06-26 AnalogifremgangsmÕte for fremstilling av et blodsubstitutt

Country Status (15)

Country Link
EP (1) EP0507870B1 (no)
JP (1) JP2954347B2 (no)
KR (1) KR0168866B1 (no)
AT (1) ATE136466T1 (no)
AU (1) AU650439B2 (no)
CA (1) CA2072081C (no)
DE (1) DE69026513T2 (no)
DK (1) DK0507870T3 (no)
ES (1) ES2086532T3 (no)
FI (1) FI105256B (no)
GR (1) GR3019775T3 (no)
IE (1) IE73248B1 (no)
NO (1) NO309799B1 (no)
PT (1) PT96398B (no)
WO (1) WO1991009615A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650388A (en) * 1989-11-22 1997-07-22 Enzon, Inc. Fractionated polyalkylene oxide-conjugated hemoglobin solutions
DE69130483T2 (de) * 1991-02-12 1999-06-10 Univ Texas Tech Verbesserter blutersatz
US5334706A (en) * 1992-01-30 1994-08-02 Baxter International Administration of low dose hemoglobin to increase perfusion
US5900477A (en) * 1992-01-30 1999-05-04 Baxter International, Inc. Use of hemoglobin in the treatment of hemorrhagic shock
US5264555A (en) * 1992-07-14 1993-11-23 Enzon, Inc. Process for hemoglobin extraction and purification
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
US6242417B1 (en) 1994-03-08 2001-06-05 Somatogen, Inc. Stabilized compositions containing hemoglobin
EP0767675A4 (en) * 1995-04-10 1998-08-05 Baxter Int USE OF CROSS-LINKED HEMOGLOBIN IN THE TREATMENT OF SUBARACHNOIDAL BLEEDING
US5741894A (en) * 1995-09-22 1998-04-21 Baxter International, Inc. Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form
KR100674690B1 (ko) * 1999-07-01 2007-01-25 시스멕스 가부시키가이샤 헤모글로빈 안정화수단
CN116941603A (zh) * 2023-07-21 2023-10-27 浙江康嘉基因技术有限公司 一种新型醛化鸡红细胞的制备方法及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4061736A (en) * 1975-02-02 1977-12-06 Alza Corporation Pharmaceutically acceptable intramolecularly cross-linked, stromal-free hemoglobin
US4401652A (en) * 1980-12-31 1983-08-30 Allied Corporation Process for the preparation of stroma-free hemoglobin solutions
US4473496A (en) * 1981-09-14 1984-09-25 The United States Of America As Represented By The Secretary Of The Army Intramolecularly crosslinked hemoglobin
US4831012A (en) * 1984-03-23 1989-05-16 Baxter International Inc. Purified hemoglobin solutions and method for making same
GB8710598D0 (en) * 1987-05-05 1987-06-10 Star Medical Diagnostics Ltd Hemoglobin based blood substitute
US4876241A (en) * 1987-05-22 1989-10-24 Armour Pharmaceutical Company Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants

Also Published As

Publication number Publication date
EP0507870A4 (en) 1993-08-11
KR0168866B1 (ko) 1999-01-15
ES2086532T3 (es) 1996-07-01
CA2072081C (en) 2002-07-30
NO309799B1 (no) 2001-04-02
NO922551D0 (no) 1992-06-26
KR920703087A (ko) 1992-12-17
AU650439B2 (en) 1994-06-23
ATE136466T1 (de) 1996-04-15
DE69026513T2 (de) 1996-09-12
FI105256B (fi) 2000-07-14
JP2954347B2 (ja) 1999-09-27
WO1991009615A1 (en) 1991-07-11
JPH05504766A (ja) 1993-07-22
IE73248B1 (en) 1997-05-21
FI922937A (fi) 1992-06-24
PT96398B (pt) 1998-12-31
DE69026513D1 (de) 1996-05-15
EP0507870A1 (en) 1992-10-14
FI922937A0 (fi) 1992-06-24
PT96398A (pt) 1991-10-31
AU7142591A (en) 1991-07-24
EP0507870B1 (en) 1996-04-10
GR3019775T3 (en) 1996-07-31
CA2072081A1 (en) 1991-06-30
IE904717A1 (en) 1991-07-17
DK0507870T3 (da) 1996-06-10

Similar Documents

Publication Publication Date Title
NO922551D0 (no) Polyhemoglobin stabilisert ved hjelp av purinderivater ogglutation
CA2009637A1 (en) Substituted-1,3-oxathiolanes with antiviral properties
DK0430045T3 (da) Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion
CA2100269A1 (en) Use of 1, 3-Oxathiolane Nucleoside Analogues in the Treatment of Hepatitis B
DE3853477T2 (de) Makrozyklische verbindungen.
KR930023370A (ko) 단백질 씨(c) 유도체
MY105523A (en) Substituted-1,3-oxathiolanes with antiviral properties.
MX9203320A (es) Composicion antialergica que contiene compuestos biciclicos switterionicos.
EP1468680A3 (en) Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood
DE69130483D1 (de) Verbesserter blutersatz
ES2043959T3 (es) Preparado farmaceutico estabilizado, que contiene n-acetilcisteina.
AU4425589A (en) Nucleoside derivatives
PH27369A (en) Glutaric acid derivatives and preparations thereof
AU2836889A (en) A stabilizing agent and an injectable composition containing the same
TH14151EX (th) อนุพันธ์ต่าง ๆ ของอิมิดาโซลที่เป็นตัวต่อต้านฤทธิ์แอนจิโอเทนซิน ii, การเตรียมสารเหล่านี้และการใช้สารเหล่านี้บำบัดโรค
TH14318EX (th) นิวคลีโอไซด์ที่ใช้ในการรักษาโรค

Legal Events

Date Code Title Description
MK1K Patent expired